Dual regulation of leptin secretion: intracellular energy and calcium dependence of regulated pathway.
Rodent leptin is secreted by adipocytes and acutely regulates appetite and chronically regulates body weight. Mechanisms for leptin secretion in cultured adipocytes were investigated. Acutely, energy-producing substrates stimulated leptin secretion about twofold. Biologically inert carbohydrates failed to stimulate leptin secretion, and depletion of intracellular energy inhibited leptin release. There appears to be a correlation between intracellular ATP concentration and the rate of leptin secretion. Insulin increased leptin secretion by an additional 25%. Acute leptin secretion is calcium dependent. When incubated in the absence of calcium or in the presence of intracellular calcium chelators, glucose plus insulin failed to stimulate leptin secretion. In contrast, basal leptin secretion is secreted spontaneously and is calcium independent. Adipocytes from fatter animals secrete more leptin, even in the absence of calcium, compared with cells from thinner animals. Acute stimulus-secretion coupling mechanisms were then investigated. The potassium channel activator diazoxide and the nonspecific calcium channel blockers nickel and cadmium inhibited acute leptin secretion. These studies demonstrate that intracellular energy production is important for acute leptin secretion and that potassium and calcium flux may play roles in coupling intracellular energy production to leptin secretion.
Levy
J R
JR
Section of Endocrinology and Metabolism, McGuire Veterans Administration Medical Center and Medical College of Virginia/Virginia Commonwealth University, Richmond, Virginia 23249, USA. James.Levy@med.va.gov
Gyarmati
J
J
Lesko
J M
JM
Adler
R A
RA
Stevens
W
W
D000255:Adenosine Triphosphate / Q000378:metabolism; D017667:Adipocytes / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D001835:Body Weight; D002104:Cadmium / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology*; D002121:Calcium Channel Blockers / Q000494:pharmacology; D002478:Cells, Cultured; D003981:Diazoxide / Q000494:pharmacology; D004734:Energy Metabolism; D007328:Insulin / Q000494:pharmacology; D020738:Leptin / Q000378:metabolism*; D008297:Male; D009532:Nickel / Q000494:pharmacology; D015221:Potassium Channels / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley
D002121:Calcium Channel Blockers; D007328:Insulin; D020738:Leptin; D015221:Potassium Channels; D002104:Cadmium; D009532:Nickel; D000255:Adenosine Triphosphate; D003981:Diazoxide; D002118:Calcium